Annual Drug Patent Expirations for ADZENYS+XR-ODT
Adzenys Xr-odt is a drug marketed by Neos Theraps and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
ADZENYS XR-ODT drug price trends.
Drug patent litigation for ADZENYS XR-ODT.
This drug has two patent family members in two countries.
The generic ingredient in ADZENYS XR-ODT is amphetamine. One supplier is listed for this compound. Additional details are available on the amphetamine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
